SLYG vs VTI

SLYG vs VTI

Which is better, SLYG or VTI?

Small Cap Growth against Large Cap Blend.

VTI has a lower expense ratio. SLYG led over 1Y, VTI over 3Y, 5Y and the full window. The two have moved almost in lockstep, correlation 0.90. SLYG is less concentrated, with 10.0% of the fund in its ten largest positions against 33.3%.

Lower Fees: VTIHigher Returns: splitLess Concentrated: SLYG

MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.

Side-by-Side Comparison

MetricSLYGVTI
Expense Ratio0.15%0.03%Best
AUM$4.8B$690.1B
Dividend Yield0.67%1.03%
Holdings3513,524
YTD Return+15.13%Best+13.35%
1Y Return+16.06%Best+15.92%
3Y Return (annualized)+16.07%+23.41%Best
5Y Return (annualized)+5.53%+12.83%Best
Volatility (annualized)20.6%15.3%Best
Max Drawdown-60.4%-56.6%Best
$10,000 over 5 years$13,088$18,286Best
Top 10 Weight10.0%Best33.3%
Fund FamilyState Street Investment ManagementVanguard (US)
CategoryEquityEquity
StyleSmall Cap GrowthLarge Cap Blend
InceptionSep 25, 2000May 24, 2001

Volatility and max drawdown are measured over the window both funds cover: May 31, 2001 to Oct 2, 2026 (25.3 years).

SLYG vs VTI growth

Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 25.3 years both funds cover.

SLYG vs VTI Performance

State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) is an ETF from State Street Investment Management and Vanguard Morningstar Total Stock Market ETF (VTI) is an ETF from Vanguard (US). Over the past year SLYG returned +16.06% while VTI returned +15.92%. Year to date, SLYG is up 15.13% versus a gain of 13.35% for VTI.

Over three years, SLYG compounded at +16.07% per year against +23.41% for VTI; over five years the annualized figures are +5.53% and +12.83% respectively. Across the full 25-year window we track, VTI has the edge at +8.06% annualized vs +7.27%.

Past performance does not guarantee future results.

Risk: Volatility and Drawdowns

SLYG has been the more volatile fund, with annualized monthly volatility of 20.6% compared with 15.3% for VTI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.

The deepest peak-to-trough decline in our data was -60.4% for SLYG and -56.6% for VTI. Drawdown depth is what each fund did in the worst stretch of the window measured above.

The two funds' monthly returns correlate at 0.90. They move almost in lockstep, so holding both mostly duplicates the same exposure.

Fees and Cost Over Time

SLYG charges 0.15% per year while VTI charges 0.03%. On a $10,000 position that is $15 vs $3 annually, a gap of $12 per year that compounds over a long holding period. On income, SLYG currently yields 0.67% against 1.03% for VTI.

Holdings Overlap

SLYG already in VTI97.4%
VTI already in SLYG1.3%

97.4% of SLYG's money is in holdings VTI also owns. 1.3% of VTI's money is in holdings SLYG also owns.

Most of SLYG is already inside VTI. Owning both mostly buys the same companies twice.

340 positions in common, counted across the 351 positions we hold weights for in SLYG and 3,463 in VTI, against full books of 351 and 3,524.

What only one of them owns

Our book lists 1,020 positions for VTI that do not appear in our book for SLYG (96.2% of the fund), and 9 for SLYG that do not appear in VTI (2.0%).

Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.

Top Shared Holdings

StockWeight in SLYGWeight in VTIDifference
CORTCorcept Therapeutics Incorporated1.27%0.01%1.26%
VSATViasat Inc1.19%0.01%1.18%
EATBrinker International, Inc.1.07%0.01%1.06%
FORMFormfactor, Inc.1.05%0.01%1.04%
PTGXProtagonist Therapeutics Inc1.05%0.01%1.04%
RHPRyman Healthcare Limited0.98%0.01%0.97%
ALKS:IEAlkermes Plc. Ordinary Shares0.90%0.01%0.89%
SNEXStonex Group Inc0.87%0.01%0.86%
TGTXTg Therapeutics Inc Common Stock0.83%0.01%0.82%
MSGSMadison Square Garden Co/the0.83%0.00%0.83%

97.4% of SLYG is already inside VTI.

You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.

SLYGVTI

Free for up to 10 holdings. No account needed.

Frequently Asked Questions

Which is cheaper, SLYG or VTI?

SLYG has an expense ratio of 0.15% while VTI charges 0.03%. VTI is the cheaper option, by $12 a year on a $10,000 investment.

Which performed better, SLYG or VTI?

Over the past year SLYG returned +16.06% vs +15.92% for VTI, so SLYG leads on 1-year performance. Over the longest common window we track (25 years), SLYG annualized +7.27% vs +8.06% for VTI. Past performance does not guarantee future results. This is information, not a recommendation.

Which is riskier, SLYG or VTI?

SLYG has been the more volatile fund at 20.6% annualized versus 15.3% for VTI. Worst drawdown: SLYG -60.4% vs VTI -56.6%.

Should I hold both SLYG and VTI?

SLYG and VTI have a monthly-return correlation of 0.90, so they move almost identically. What is left to separate them is the fee and the index each one tracks. This is information, not a recommendation.

What is the holdings overlap between SLYG and VTI?

97.4% of SLYG's money is in holdings VTI also owns. 1.3% of VTI's is in holdings SLYG also owns. They hold 340 positions in common, counted across the 351 positions we hold weights for in SLYG and 3,463 in VTI.

Which pays a higher dividend, SLYG or VTI?

SLYG yields 0.67% while VTI yields 1.03%, so VTI currently pays the higher dividend yield.

Is VTI better than SLYG?

VTI has a lower expense ratio. SLYG led over 1Y, VTI over 3Y, 5Y and the full window. The two have moved almost in lockstep, correlation 0.90. SLYG is less concentrated, with 10.0% of the fund in its ten largest positions against 33.3%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.